SIRT1-mediated deacetylation of NF-κB inhibits the MLCK/MLC2 pathway and the expression of ET-1, thus alleviating the

Bo-Wen Wu1,2, Mi-Shan Wu2,3, Yu Liu1,2

  • 1Department of Biochemistry, Basic Medicine College, Hebei University of Chinese Medicine, Shijiazhuang, People's Republic of China.

Insights

Sirtuin-1 (SIRT1) alleviates coronary artery spasm (CAS) by inhibiting vascular smooth muscle cell proliferation and contraction. SIRT1 deacetylates NF-κB, disrupting the MLCK/MLC2 pathway and reducing ET-1 expression to prevent CAS.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Cellular Physiology

Background:

  • Coronary artery spasm (CAS) involves intense vasoconstriction causing vessel occlusion.
  • Sirtuin-1 (SIRT1) demonstrates cardioprotective effects in coronary artery disease.
  • The precise molecular mechanisms of SIRT1 in alleviating CAS require further elucidation.

Purpose of the Study:

  • To investigate the molecular mechanism by which SIRT1 alleviates CAS.
  • To determine the role of SIRT1 in regulating vascular smooth muscle cell (VSMC) function in CAS.
  • To explore the signaling pathways modulated by SIRT1 in CAS.

Main Methods:

  • Established an endothelin-1 (ET-1)-induced rat CAS model.
  • Quantified SIRT1 expression using RT-qPCR and Western blot.
  • Analyzed molecular interactions via luciferase reporter assays, RT-qPCR, and Western blot.
  • Assessed VSMC contraction, proliferation, and protein expression following SIRT1 manipulation in vitro.

Main Results:

  • SIRT1 expression was significantly reduced in rat CAS models.
  • Overexpression of SIRT1 inhibited VSMC contraction and proliferation in vitro.
  • SIRT1 inhibited nuclear factor-kappaB (NF-κB) expression via deacetylation.
  • NF-κB activation of the myosin light chain kinase/myosin light chain-2 (MLCK/MLC2) pathway and ET-1 upregulation were identified as key mechanisms.

Conclusions:

  • SIRT1 alleviates CAS by deacetylating NF-κB, thereby inhibiting the NF-κB/MLCK/MLC2/ET-1 signaling axis.
  • This mechanism reduces VSMC contraction and proliferation, offering a potential therapeutic target for CAS.
  • SIRT1's role in modulating VSMC function provides a theoretical basis for CAS treatment and prevention strategies.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.2K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.9K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
534